In conclusion, our study found that increased SULF1 expression is significantly predictive of more advanced tumor stage and poorer metastasis-free survival and disease-specific survival in patients with both UTUC and UBUC. This evidence concerns the gene SULF1 and renal pelvis/ureter urothelial carcinoma.